文献速递免疫规划传染病防控与疫情报告

霍乱流行国家不同年龄组口服霍乱疫苗接种后抗体分泌细胞与粪便IgA应答的动力学

Kinetics of antibody-secreting cell and fecal IgA responses after oral cholera vaccination in different age groups in a cholera endemic country.
PubMed 文献 · Vaccine · 2017-01-01

在孟加拉国霍乱流行区,对婴儿(6-11月龄)、幼儿(12-18月龄)、学步儿(19月龄-5岁)和成人间隔2周接种两剂口服霍乱疫苗Dukoral,评估接种后4/5天和7天的抗体分泌细胞(ASC)/ALS IgA、血浆IgA/IgG及粪便SIgA应答。结果提示两剂疫苗后ASC/ALS应答应比先前推荐的第7天更早分析,粪便抗体应答宜晚于ASC/ALS分析。

要点

  • 首剂后成人和学步儿抗CTB ALS IgA应答第5天与第7天高且相当,幼儿应答低且不频繁。
  • 第二剂后所有年龄组ASC/ALS应答在第5天最高,至第7天下降。
  • 幼儿和婴儿粪便SIgA应答在第二剂后第7天最高。

核心结论

  • 两剂口服霍乱疫苗Dukoral及相关口服疫苗的ASC/ALS应答应在所有年龄组比先前推荐的第7天更早分析。
  • 粪便抗体应答宜比ASC/ALS应答更晚分析以检测最高抗体应答。

研究设计与样本

  • 在霍乱流行国家孟加拉国,对婴儿(6-11月龄)、幼儿(12-18月龄)、学步儿(19月龄-5岁)和成人间隔2周接种两剂口服霍乱疫苗Dukoral(含霍乱毒素B亚单位rCTB和灭活霍乱弧菌)。
  • 每次接种后4/5天和7天评估ALS法检测的IgA ASC应答、血浆IgA和IgG应答及粪便提取物中SIgA应答。

主要发现

  • 首剂后,成人和学步儿抗CTB ALS IgA应答在第5天和第7天高且相当,幼儿应答低且不频繁。
  • 第二剂后,所有年龄组ASC/ALS应答在研究时间点中以第5天最高,至第7天下降。
  • 第二剂后第5天和第7天血浆抗CTB IgA和IgG应答均高。
  • 幼儿和婴儿粪便SIgA应答在第二剂后第7天最高。

临床怎么用

  • 作者认为两剂口服霍乱疫苗Dukoral及相关口服疫苗的ASC/ALS应答应在所有年龄组比先前推荐的第7天更早分析。
  • 作者认为粪便抗体应答宜比ASC/ALS应答更晚分析以检测最高抗体应答。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Immune responses to oral enteric vaccines in children and infants may be influenced by factors such as age, previous priming with related microorganisms and breast feeding. In this study, we aimed to determine optimal time points to assess immune responses to oral enteric vaccines in different clinical specimens. This was done by investigating antibody secreting cell (ASC) and fecal antibody responses on different days after vaccination using the licensed oral cholera vaccine Dukoral, containing cholera toxin B-subunit (rCTB) and inactivated Vibrio cholerae bacteria, as a model vaccine. Two vaccine doses were given 2weeks apart to infants (6-11months), young children (12-18months), toddlers (19months-5years) and adults in a cholera endemic country (Bangladesh). IgA ASC responses, as determined by the antibodies in lymphocyte supernatant (ALS) assay, plasma IgA and IgG responses and secretory IgA (SIgA) responses in extracts of fecal samples were evaluated 4/5 and 7days after each vaccination. After the first vaccine dose, anti-CTB ALS IgA responses in adults and toddlers were high and comparable on day 5 and 7, while responses were low and infrequent in young children. After the second dose, highest ALS responses were detected on day 5 among the time points studied in all age groups and the responses declined until day 7. In contrast, plasma IgA and IgG anti-CTB responses were high both on day 5 and 7 after the second dose. Fecal SIgA responses in young children and infants were highest on day 7 after the second dose. Our results suggest that ASC/ALS responses to two doses of the oral cholera vaccine Dukoral and related oral vaccines should be analyzed earlier than previously recommended (day 7) at all ages. Fecal antibody responses should preferably be analyzed later than ASC/ALS responses to detect the highest antibody responses.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Akhtar M, Qadri F, Bhuiyan TR, et al. Kinetics of antibody-secreting cell and fecal IgA responses after oral cholera vaccination in different age groups in a cholera endemic country. Vaccine. 2017. PMID: 27916412. doi:10.1016/j.vaccine.2016.11.055

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。